23 General introduction 1 19. Wyllie AH: Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284:555-6, 1980 20. Haarman EG, Kaspers GJ, Veerman AJ: Glucocorticoid resistance in childhood leukaemia: mechanisms and modulation. Br J Haematol 120:919-29, 2003 21. Kaspers GJL, Veerman AJP, PoppSnijders C, et al: Comparison of the antileukemic activity in vitro of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia. Medical and Pediatric Oncology 27:114-121, 1996 22. Styczynski J, Wysocki M, Balwierz W, et al: In vitro comparative antileukemic activity of various glucocorticoids in childhood acute leukemia. Neoplasma 49:178-83, 2002 23. Ito C, Evans WE, McNinch L, et al: Comparative cytotoxicity of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia. J Clin Oncol 14:2370-6, 1996 24. Grossmann C, Scholz T, Rochel M, et al: Transactivation via the human glucocorticoid and mineralocorticoid receptor by therapeutically used steroids in CV-1 cells: a comparison of their glucocorticoid and mineralocorticoid properties. Eur J Endocrinol 151:397-406, 2004 25. Kaspers GJ, Veerman AJ, Popp-Snijders C, et al: Comparison of the antileukemic activity in vitro of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia. Med Pediatr Oncol 27:114-21, 1996 26. Teuffel O, Kuster SP, Hunger SP, et al: Dexamethasone versus prednisone for induction therapy in childhood acute lymphoblastic leukemia: a systematic review and meta-analysis. Leukemia 25:1232-8, 2011 27. Felder-Puig RS, C.; Baumgartner, M.; Ortner, M.; Aschenbrenner, C.; Bieglmayer, C.; Voigtlander, T.; Panzer-Grumayer, E. R.; Tissing, W. J.; Koper, J. W.; Steinberger, K.; Nasel, C.; Gadner, H.; Topf, R.; Dworzak, M.: Glucocorticoids in the treatment of children with acute lymphoblastic leukemia and hodgkin’s disease: a pilot study on the adverse psychological reactions and possible associations with neurobiological, endocrine, and genetic markers. Clin Cancer Res 13:7093-100, 2007 28. Stuart FA, Segal TY, Keady S: Adverse psychological effects of corticosteroids in children and adolescents. Arch Dis Child 90:500-6, 2005 29. Warris LT, van den Akker ELT, Bierings MB, et al: Eating behavior during dexamethasone treatment in children with acute lymphoblastic leukemia. Pediatr Blood Cancer 64, 2017 30. Rogers VE, Zhu S, Ancoli-Israel S, et al: Impairment in circadian activity rhythms occurs during dexamethasone therapy in children with leukemia. Pediatr Blood Cancer 61:1986-91, 2014 31. Fardell JE, Vetsch J, Trahair T, et al: Health-related quality of life of children on treatment for acute lymphoblastic leukemia: A systematic review. Pediatr Blood Cancer 64, 2017 32. McGrath P, Pitcher L: ‘Enough is enough’: qualitative findings on the impact of dexamethasone during reinduction/consolidation for paediatric acute lymphoblastic leukaemia. Support Care Cancer 10:146-55, 2002 33. Aljebab F, Choonara I, Conroy S: Systematic Review of the Toxicity of Long-Course Oral Corticosteroids in Children. PLoS One 12:e0170259, 2017 34. Hochhauser CJ, Lewis M, Kamen BA, et al: Steroid-induced alterations of mood and behavior in children during treatment for acute lymphoblastic leukemia. Support Care Cancer 13:967-74, 2005 35. Warris LT, van den Heuvel-Eibrink MM, Aarsen FK, et al: Hydrocortisone as an Intervention for Dexamethasone-Induced Adverse Effects in Pediatric Patients With Acute Lymphoblastic Leukemia: Results of a Double-Blind, Randomized Controlled Trial. J Clin Oncol 34:2287-93, 2016
RkJQdWJsaXNoZXIy MTk4NDMw